Fortis Healthcare Ltd

FORTISHospital
891.30+0.00 (+0.00%)
As on 09 Feb 2026, 12:13 pmMarket Closed

Fundamental Score

...

Fortis Healthcare Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

10.13%
Poor

Return on Capital Employed

11.96%
Excellent

Operating Profit Margin (5Y)

17.68%
Poor

Dividend Yield

0.11%

Valuation Metrics

Poor

Price to Earnings

67.80x

Market Capitalization

68.30K (Cr)

Industry P/E

52.84x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

40.23%
Good

YoY Quarterly Sales Growth

17.25%
Average

Sales Growth (5Y)

10.93%
Excellent

EPS Growth (5Y)

70.31%
Excellent

Profit Growth (5Y)

70.31%

Financial Health

Excellent

Debt to Equity

0.34x
Excellent

Interest Coverage

6.00x
Excellent

Free Cash Flow (5Y)

2.15K (Cr)

Ownership Structure

Average

Promoter Holding

31.17%
Excellent

FII Holding

27.90%
Excellent

DII Holding

29.14%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.
31.17%
Promoter Holding
68.30K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of FORTIS across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Operating Margins (17.68%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Robust Profit Growth (40.23%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (17.25%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Excellent EPS Growth (70.31% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (70.31% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Strong Interest Coverage (6.00x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Strong Cash Generation (₹2154.48 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 57.04%)

Observation: Significant professional investor participation indicates quality recognition.

Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Premium Valuation Risk (P/E: 67.80x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Financial Statements

Comprehensive financial data for Fortis Healthcare Ltd

About FORTIS

Business Overview

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplant, rheumatology, thoracic surgery, transfusion medicine, urology, medical generics, endocrine surgery, and other support specialties, as well as treat infectious diseases. The company's healthcare verticals comprise hospitals, diagnostics, tertiary and quaternary care, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.

Company Details

Symbol:FORTIS
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Ashutosh Raghuvanshi
MD, CEO & Director
Mr. Vivek Kumar Goyal
Chief Financial Officer
Mr. Satyendra Chauhan
Company Secretary & Compliance Officer

FORTIS Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)10.13%
Return on Capital Employed11.96%
Operating Profit Margin (5Y)17.68%
Debt to Equity Ratio0.34
Interest Coverage Ratio6.00

Growth & Valuation

Sales Growth (5Y)10.93%
Profit Growth (5Y)70.31%
EPS Growth (5Y)70.31%
YoY Quarterly Profit Growth40.23%
YoY Quarterly Sales Growth17.25%

Frequently Asked Questions

What is the current price of Fortis Healthcare Ltd (FORTIS)?

As of 09 Feb 2026, 12:13 pm IST, Fortis Healthcare Ltd (FORTIS) is currently trading at ₹891.30. The stock has a market capitalization of ₹68.30K (Cr).

Is FORTIS share price Overvalued or Undervalued?

FORTIS is currently trading at a P/E ratio of 67.80x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Fortis Healthcare Ltd share price?

Key factors influencing FORTIS's price include its quarterly earnings growth (Sales Growth: 17.25%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Fortis Healthcare Ltd a good stock for long-term investment?

Fortis Healthcare Ltd shows a 5-year Profit Growth of 70.31% and an ROE of 10.13%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.34 before investing.

How does Fortis Healthcare Ltd compare with its industry peers?

Fortis Healthcare Ltd competes with major peers in the Hospital. Investors should compare FORTIS's P/E of 67.80x and ROE of 10.13% against the industry averages to determine its competitive standing.

What is the P/E ratio of FORTIS and what does it mean?

FORTIS has a P/E ratio of 67.80x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹68 for every ₹1 of annual earnings.

How is FORTIS performing according to Bull Run's analysis?

FORTIS has a Bull Run fundamental score of 55.6/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does FORTIS belong to?

FORTIS operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Fortis Healthcare Ltd.

What is Return on Equity (ROE) and why is it important for FORTIS?

FORTIS has an ROE of 10.13%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Fortis Healthcare Ltd generates profits from shareholders' equity.

How is FORTIS's debt-to-equity ratio and what does it indicate?

FORTIS has a debt-to-equity ratio of 0.34, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is FORTIS's dividend yield and is it a good dividend stock?

FORTIS offers a dividend yield of 0.11%, which means you receive ₹0.11 annual dividend for every ₹100 invested.

How has FORTIS grown over the past 5 years?

FORTIS has achieved 5-year growth rates of: Sales Growth 10.93%, Profit Growth 70.31%, and EPS Growth 70.31%.

What is the promoter holding in FORTIS and why does it matter?

Promoters hold 31.17% of FORTIS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is FORTIS's market capitalization category?

FORTIS has a market capitalization of ₹68301 crores, placing it in the Large-cap category.

How volatile is FORTIS stock?

FORTIS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for FORTIS?

FORTIS has a 52-week high of ₹N/A and low of ₹N/A.

What is FORTIS's operating profit margin trend?

FORTIS has a 5-year average Operating Profit Margin (OPM) of 17.68%, indicating the company's operational efficiency.

How is FORTIS's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 17.25% and YoY Profit Growth of 40.23%.

What is the institutional holding pattern in FORTIS?

FORTIS has FII holding of 27.90% and DII holding of 29.14%. Significant institutional holding often suggests professional confidence in the stock.